Search

OCCULT NODAL METASTASIS IN SURGICALLY TREATED HPV-RELATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA

Oropharynx / HPV Related Disease

Austin C Cao, BA; Erin R Cohen, MD; Robert M Brody, MD

University of Pennsylvania Department of Otorhinolaryngology- Head and Neck Surgery

DETERMINING THE ROLE OF HPV INTEGRATION IN OROPHARYNGEAL SQUAMOUS CELL CARCINOMA

Oropharynx / HPV Related Disease

Wesley H Stepp, MD, PhD; Natalia Isaeva, PhD; Wendell G Yarbrough, MD; Trevor G Hackman, MD; Travis P Schrank, MD, PhD

University of North Carolina at Chapel Hill

FACILITY TYPE PREDICTS TREATMENT REGIMEN FOR HPV-POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA

Oropharynx / HPV Related Disease

Monica S Trent, MD; Kelsey Roman, BS; Tjoson Tjoa, MD

University of California, Irvine

PREDICTING EXTRANODAL EXTENSION IN EARLY-STAGE HUMAN PAPILLOMA VIRUS-DRIVEN OROPHARYNGEAL CANCER: MACHINE LEARNING USING PET CT AND CLINICAL PARAMETERS.

Oropharynx / HPV Related Disease

Thomas D Milner, Dr; Don Wilson, Dr; Patrick Martineau, Dr; Ingrid Bloise, Dr; Carlos Uribe, Mr; Anat Dinur, Dr; Eitan Prisman, Dr

Vancouver General Hospital

EVOLVING BEYOND THE "UNKNOWN PRIMARY": TRANSORAL SURGERY FACILITATES ROUTINE IDENTIFICATION OF A T1-MICROSCOPIC P16+ OROPHARYNGEAL SCC

Oropharynx / HPV Related Disease

F. Christopher Holsinger, Professor Head and Neck Surgery¹; Michael C Topf, Assistant Professor OHNS²; Ryan K Orosco, Assistant Professor OHNS³; Andrew C Birkland, Assistant Professor OHNS⁴; Nikita Bedi, Clinical Research Coordinator¹; A. Dimitrios Colevas, Professor Medical Oncology¹; Beth M Beadle, Professor Radiation Oncology¹

¹Stanford University; ²Vanderbilt University; ³University of California at San Diego; ⁴University of California at Davis

THE COST IMPLICATIONS OF A PROPOSED MODIFIED SURVEILLANCE STRATEGY TO DETECT DISEASE RECURRENCE IN HPV+ OROPHARYNGEAL CARCINOMA UTILIZING PLASMA CIRCULATING TUMOR HPV DNA: A SINGLE INSTITUTION'S EXPERIENCE.

Oropharynx / HPV Related Disease

Michael Lin¹; Alexander Zhu, MD²; Katherine L Fedder, MD³; Mark J Jameson, MD, PhD, FACS³; Paul Read, MD, PhD²; Christopher McLaughlin, MD²; Jonathan C Garneau, MD³

¹UVA School of Medicine; ²UVA Radiation Oncology; ³UVA Otolaryngology